There are 24 partner institutions in your area

Integrity Leads the Future, Excellence Drives Action

Laos GMP Certification | SGS Batch Testing

Since 2018 | Served 27 national enterprises

Enterprise Origins

Anda Pharmaceuticals (Hong Kong) Limited

Since its establishment, quality has been the cornerstone of our enterprise. Keeping pace with health consumption trends, we leverage multi-target technology platforms and intelligent manufacturing systems as engines to deeply cultivate the fields of metabolic diseases and precision weight management.

By building a globally vertically integrated “R & D-Production-Marketing” network, we have gradually developed into an innovation-driven comprehensive pharmaceutical leader covering the Asia-Pacific market with multiple patents in the metabolic field, continuously fulfilling our mission of “Protecting Human Health through Science”.

2018

Hong Kong R & D Center Established

2023

First GLP-1 Biosimilar Approved

2025

Oral Formulation Awarded “Asia-Pacific Breakthrough Therapy”

Technology Migration Path

Aerospace Materials

GLP-1 Purification Technology

Strength Foundation, Intelligent Innovation for Future

Cross-border technology empowers new pharmaceutical strength, we are committed to providing
innovative solutions for metabolic disease patients worldwide

Science-Driven Health

Leveraging multi-target technology platforms and digital therapeutics, we pioneer precision metabolic regulation and sustainable weight management solutions with our flagship product Vetion®

Metabolic Wellness Innovated

Vetion® (GLP-1 receptor agonist) delivers dual efficacy: treating type 2 diabetes while enabling sustained weight management for obesity and metabolic disorders

Phase III Clinical Data

24 weeks

15.2 kg

Average Weight Loss

Global Patient Hub

Headquartered in Hong Kong with global operations, we deliver customized solutions through localized partnerships to meet evolving patient needs worldwide

Cross-Industry Tech

Inheriting decades in biomaterials & intelligent systems, we deploy cross-industrial tech migration and anti-cyclical economic models to build unrivalled pharmaceutical capabilities

Raw Material Purity

≥99.2%

Optimal

Real-time Workshop Environment Monitoring

Temperature

0

Normal Range

Humidity

0 %

Normal Range

Cleanliness

Grade 0 K

Meets Standard

Batch Pass Rate

0 %

MoM +0.2%

Product Batch

VT 2023056

Semaglutide Injection

Production Progress

75%

75% Completed

Production Process Video

International GMP Production System

Leading global standards, Anda Pharmaceuticals ensures the exceptional quality of every
batch with world-class production facilities and strict quality control systems

Five-Dimensional Capability Display

Anda Pharmaceuticals' production system covers five key dimensions, ensuring full quality control from raw materials to finished products, meeting the strictest pharmaceutical standards worldwide

International High Standard Construction

Compliance design benchmarked by FDA/EMA, 100,000-class clean workshop ensuring absolute cleanliness of production environment

Multi-system Certification Support

ISO quality system foundation, Lao GMP certification, building a full-chain compliance network for R&D-production-distribution

Integrated Digital Factory

Seamless integration of formulation-active pharmaceutical ingredient-packaging, with MES system real-time monitoring of the entire production process

Global Compliance Export

Professional cold chain logistics with temperature control system ensuring product quality, fast approval in Southeast Asia within 6-8 weeks

Transparent Production

Open "appointment audit workshop" and provide factory VR tour to ensure transparent and traceable production process

Corporate Qualifications and Values

Integrity Pharmaceuticals · Based in Laos · Connecting the World

Holding the GMP certification from the Lao Ministry of Health, strictly following national pharmaceutical production standards, focusing on the development of high-demand
pharmaceuticals. We build trust through transparent production:

Compliance Assurance

The entire process complies with Lao FDA regulations and supports official website qualification verification.

Quality Controllable

The production process refers to WHO-GMP guidelines, raw materials are purchased from EDQM-certified suppliers, and each batch provides SGS third-party testing reports (purity ≥99%).

Customization Capability

Flexibly adapting to registration standards in Southeast Asia, Latin America, Africa and other regions, providing one-stop solutions from formulation to packaging.

Open Cooperation

Customers are welcome to book on-site audits of workshops and laboratories to witness the 100,000-class clean production line based locally and serving globally.

GMP Certificate Verification

Lao-MOH-GMP-2023-0058

Our Core Values

Practical and Efficient

People-Oriented

Professional Innovation

Green Development

Strive for Excellence

Patient First

Collaborative Win-Win

Integrity and Transparency

Future Strategic Blueprint

Moving Forward Together · Serving the World

Strategic Planning

Taking semaglutide, the star drug, as the key entry point, we deeply explore its huge potential in the field of metabolic diseases and carefully build an innovative drug matrix with GLP-1 as the core. Continuously expanding R&D paths, actively exploring new drug forms such as combination preparations, biosimilars, and oral small molecules, committed to becoming a leading enterprise in this field and contributing outstanding strength to promoting the development of metabolic disease treatment in China.

Market Layout

Based in Hong Kong, China, we will gradually realize product agency and distribution in global markets, cooperating with international markets such as Southeast Asia, the United States, and Europe for pharmaceutical OEM and import-export cooperation. Our global layout strategy ensures that products can quickly enter target markets and provide timely treatment options for local patients.

Product Ecosystem

Anda Pharmaceuticals will continuously expand its product portfolio through sustained innovation investment to provide more high-quality and effective treatment options for global patients. Our product strategy focuses on the field of metabolic diseases, aiming to provide comprehensive treatment options.

Social Responsibility

As a responsible enterprise, Anda Pharmaceuticals will actively participate in public welfare undertakings in the future, such as educational poverty alleviation, medical assistance, disaster relief, etc., to give back to society, practice corporate social responsibility, and help human health life. We believe that the success of an enterprise is not only reflected in economic benefits, but also in its contribution to society.

GLP-1 Drug Pipeline Progress

Semaglutide
Launched
Tirzepatide
Launch 2026
Oral Small Molecule
Launch 2027

Global Market Layout

Partner Countries
0 +
Partners
0 +
Production Bases
0

Product Series Expansion Plan

Product Name Dosage Form Status Launch
Semaglutide Oral Tablet/Injection Launched 2023
Tirzepatide Injection In Development 2026
Oral GLP-1 Oral Tablet Preclinical 2027

Dosage Form Comparison Table

Bioavailability
PO Tab: 75%
Cold Chain Requirement
Injection:

Strict

Social Responsibility Projects

Donated Medicines (vials)
0

Need to set up a "real-time donation counter"

Public Welfare Projects
0 +

Educational poverty alleviation, medical assistance, disaster relief, etc.

Corporate Social Responsibility Commitment

Invest 3% of annual sales in public welfare undertakings

Establish assistance fund for metabolic disease patients

Carry out metabolic health science popularization activities

Promote green production and reduce environmental impact

Corporate Culture and Mission

Safeguarding Health, Healing Thousands of Families

To become an outstanding innovative leader in the global metabolic health and
weight management field

Patient First, Responsible Commitment

Patient needs-centered, providing safe and effective treatment options to help patients regain healthy lives.

20kg Weight Loss Real Case

Click to view full video

Collaborative Win-Win, Ecosystem Co-construction

Working closely with global partners to build an open and win-win pharmaceutical ecosystem.

Partners

Dr. Reddy's

Biocon

Lonza

Biocon

Sun Pharma

Integrity and Transparency, Compliance as Foundation

Adhering to integrity management, strictly complying with various regulations and standards, ensuring product quality and transparent and controllable production processes.

Real-time Workshop Environment Monitoring

All Normal

Cleanliness
0 K+
Humidity
0 %
Temperature
0
Pressure Difference
0 Pa

Humanistic Care

Heart-Driven Dreams, Empowering Every Step of Growth

We value the growth and development of employees, providing a complete training system and career development channels to enable each employee to realize their self-worth.

Action-Backed Responsibility, Warming Every Corner of Society

Actively participating in social public welfare undertakings, carrying out medical assistance, educational support and other activities, giving back to society with practical actions and passing on warmth.

Integrity for Longevity, Guarding Every Moment of Trust

Adhering to integrity as the foundation, quality as life, winning customers' trust and support with professional services and high-quality products.

Employee Growth Timeline

Orientation Training

Comprehensive industry knowledge and skills training

Professional Certification

Providing professional certifications such as GMP and quality management

Promotion Channel

Sound internal promotion and development mechanism

Leadership Development

Leadership development program for core talents

Global Investment Cooperation

Seeking Pharmaceutical & Healthcare Partners Worldwide · Time-Sensitive Policy with Milestone Incentives Available

OEM Franchise Inquiry

    Contact Information

    Company Address

    15th Floor, Building A, Biomedical Innovation Park, 88 Keyuan Road, Zhangjiang High-tech Park, Pudong New Area, Shanghai

    Phone Number

    +86 400-888-9999
    Working hours: Monday-Friday 9:00-18:00

    Email Address

    oem@pharmaglp.com
    We will reply to your email within 1-2 business days

    Follow Us

    WeChat Official Account

    Scan to follow for latest cooperation information

    Inquiry Tips

    After submitting the form, our professional investment consultant will contact you within 1-2 business days to provide detailed cooperation plans and quotations.

    Select your currency